123 related articles for article (PubMed ID: 8768008)
1. [Value of prognostic factors in early stage ovarian carcinoma].
Sevelda P
Zentralbl Gynakol; 1996; 118(6):326-9. PubMed ID: 8768008
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II].
Sevelda P; Gitsch E; Dittrich C; Haider F; Czerwenka K; Schemper M; Salzer H
Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):179-85. PubMed ID: 3556307
[TBL] [Abstract][Full Text] [Related]
3. [The value of surgical staging in the early stages of ovarian carcinoma].
Salzer H; Sevelda P; Genger H; Schmidl S; Denison U; Barrada M; Vavra N; Kucera H
Wien Klin Wochenschr; 1990 Aug; 102(15):437-40. PubMed ID: 2402928
[TBL] [Abstract][Full Text] [Related]
4. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
5. [Histologic classification and morphologic prognostic factors in malignant ovarian tumors].
Horn LC; Fricke K; Krugmann J
Zentralbl Gynakol; 1995; 117(7):335-45. PubMed ID: 7668062
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
[TBL] [Abstract][Full Text] [Related]
7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
8. [-CA-125 antigen as a prognostic factor for survival in patients with epithelial ovarian carcinoma of FIGO stage I--preliminary results-].
Nagele E; Kurz C; Speiser P; Vavra N; Sevelda P
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):79-82. PubMed ID: 8647363
[TBL] [Abstract][Full Text] [Related]
9. Management of epithelial ovarian tumors of low malignant potential.
Trimble CL; Trimble EL
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S52-61. PubMed ID: 7835812
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in stage I ovarian carcinoma.
Vergote I
Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
[TBL] [Abstract][Full Text] [Related]
11. The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study.
Riener EK; Arnold N; Kommoss F; Lauinger S; Pfisterer J
Gynecol Oncol; 2004 Oct; 95(1):89-94. PubMed ID: 15385115
[TBL] [Abstract][Full Text] [Related]
12. [Borderline tumors of the ovary: a multicenter study in 137 patients].
Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
14. Granulosa cell tumor of the ovary: tumor review.
Koukourakis GV; Kouloulias VE; Koukourakis MJ; Zacharias GA; Papadimitriou C; Mystakidou K; Pistevou-Gompaki K; Kouvaris J; Gouliamos A
Integr Cancer Ther; 2008 Sep; 7(3):204-15. PubMed ID: 18815151
[TBL] [Abstract][Full Text] [Related]
15. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
16. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian cancers--a solution within reach?].
Haller U; Lütolf UM; Jungi WF
Schweiz Med Wochenschr; 1983 Sep; 113(36):1300-5. PubMed ID: 6635629
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
19. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
20. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]